Filter News
Area of Research
- (-) Materials (21)
- Advanced Manufacturing (3)
- Biology and Environment (11)
- Clean Energy (44)
- Computational Engineering (1)
- Computer Science (4)
- Electricity and Smart Grid (1)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (12)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (3)
- Materials for Computing (4)
- National Security (15)
- Neutron Science (13)
- Nuclear Science and Technology (10)
- Quantum information Science (2)
- Supercomputing (44)
News Type
News Topics
- (-) Biomedical (3)
- (-) Computer Science (8)
- (-) Grid (3)
- (-) Machine Learning (3)
- (-) Nuclear Energy (3)
- (-) Transportation (5)
- 3-D Printing/Advanced Manufacturing (13)
- Advanced Reactors (2)
- Artificial Intelligence (5)
- Bioenergy (8)
- Biology (4)
- Buildings (3)
- Chemical Sciences (21)
- Climate Change (5)
- Composites (3)
- Coronavirus (2)
- Critical Materials (8)
- Cybersecurity (3)
- Decarbonization (5)
- Energy Storage (20)
- Environment (8)
- Exascale Computing (1)
- Frontier (3)
- Fusion (2)
- High-Performance Computing (3)
- Irradiation (1)
- Isotopes (5)
- ITER (1)
- Materials (43)
- Materials Science (37)
- Microscopy (14)
- Molten Salt (2)
- Nanotechnology (21)
- National Security (3)
- Net Zero (1)
- Neutron Science (19)
- Partnerships (9)
- Physics (14)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (10)
- Renewable Energy (1)
- Security (1)
- Simulation (1)
- Summit (1)
- Sustainable Energy (8)
- Transformational Challenge Reactor (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.